Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2024-04-08 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares over various dates, including quantities and prices, and confirms compliance with listing rules. The content focuses on share repurchase activity and changes in issued shares, with no financial statements or earnings data. This matches the definition of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, not merely an announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-04-08 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares over various dates, confirming compliance with listing rules and legal requirements. The content focuses on share repurchase activities and changes in issued shares, with no financial statements or earnings data. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is over 13,000 characters and contains detailed transactional data, not just an announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-04-05 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and details changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes extensive data on repurchases of shares, dates, quantities, and prices, as well as confirmations related to compliance with listing rules. The content focuses on share repurchase activities and changes in capital structure rather than financial results, management changes, or legal matters. This matches the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback or sale of its own shares. The document is substantive and not merely an announcement or certification, so it is not classified as Regulatory Filings or Report Publication Announcement.
2024-04-03 English
Final Dividend for the Year Ended 31 December 2023 (Updated)
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Cash Dividend Announcement for Equity Issuer' and provides detailed information about the final dividend for the year ended 31 December 2023, including dividend amount, ex-dividend date, record date, payment date, and shareholder approval date. It also includes information about the share registrar and withholding tax. The document length is 3504 characters, which is relatively short and focused solely on dividend details. There is no financial performance data, management discussion, or other report content. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts and payment details to shareholders.
2024-04-03 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. There are no financial statements, earnings data, or management discussion. The document is a regulatory disclosure about share repurchases, fitting the category of Transaction in Own Shares (POS). The document length is sufficient and contains detailed transactional data, confirming it is not a mere announcement but a full disclosure report on share repurchases.
2024-04-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return on movements in securities for Kindstar Globalgene Technology, Inc., submitted to the Hong Kong Exchanges and Clearing Limited. It includes information on authorized and issued share capital, share options, repurchases, and confirmations related to securities issued. The document is regulatory in nature, reporting share capital changes and compliance confirmations under the Exchange Listing Rules. It does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report but a regulatory filing itself. Therefore, it fits best under Regulatory Filings (RNS).
2024-04-02 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.